Brief

Chemical Companies Don’t Have to Settle for Managed Decline

Cutting costs and waiting for recovery won’t work in a structural reset. Winners will boldly pursue a clear advantage.

Piet de Paepe, Laurent Migom, Jayant Gotpagar, Jeongsoo Choi, and Sachin Thukral

First published on октября 19, 2026
min read


Резюме Despite record plant closures, about 7.5% of olefin capacity must still close by 2030 to return to normal operating rates. China keeps adding capacity and moving up-market. By 2030, it's expected to hold almost a third of the specialty market. This year's price spike looks like a recovery, but it's a supply shock. Companies that wait it out will only drift further. Winners will more definitively choose where they can lead, exit where they can't, and execute an ambitious plan. The chemical industry’s downturn of the past few years isn’t an ordinary market trough. It’s a structural reset. Chronic overcapacity has compressed margins. Cheap feedstock has split the industry into haves and have-nots. China is now self-sufficient in most commodity chemicals and is expected to maintain its lead in specialty products—market territory that the West has historically relied on for higher margins. The global market is fracturing into regional blocs, and location and policy set returns as much as the cost curve does. All the while, shocks from the pandemic to this year’s closure of the Strait of Hormuz have battered the industry. Chemical executives recognize this isn’t a normal downturn, so it’s surprising that most continue to navigate it like they always have: cut costs, protect the balance sheet, and wait for demand to recover. That approach served the industry well for decades, but the transformed playing field makes the old playbook dangerously risky. Many chemical companies are unwittingly settling into a managed decline. It looks like sound strategy until the moment a rival’s cost or innovation lead becomes insurmountable. The price rise that followed the Iran conflict has opened a temporary window to reset strategy. Companies that misread the supply shock as a recovery and wait will miss the window. Overcapacity: Record closures aren’t enough Overcapacity is the industry’s defining problem of the decade. Bain analysis projects that chemical plants will continue running below their historical utilization average through 2030, and baseline projected demand growth won’t close the gap. 7.5% estimated net closure of global olefin production capacity required by 2030 We estimate it will likely require the net closure of about 7.5% of global olefin production capacity by 2030, or 35 million metric tons. It’s a scale of closure the industry has never carried out voluntarily. Europe, Korea, and Japan are cutting capacity, but it’s not enough to offset the pace of China’s capacity additions. In some products, Chinese capacity alone already matches or exceeds total world demand. Every year that closures fall short of what’s required will delay margin recovery. Furthermore, the gap widens because the lowest-cost producers keep getting cheaper while everyone else stands still. Feedstock: The divide has widened Gas-based plants now hold a lasting cost advantage. US ethane is expected to stay roughly $300 to $400 per tonne below the price of Asian naphtha. More than half of the cracker fleets in Europe, East Asia, and Southeast Asia depend on naphtha, making them the most exposed on the map (see Figure 1). China is largely shielded because roughly 40% of its feedstock is coal-based. Figure 1 Europe and parts of Asia are the most exposed to naphtha supply shocks Sources: S&P Commodity Insights; Bain analysis This year’s widening of the price spread between naphtha and ethane due to the Hormuz disruption is geopolitical noise and doesn’t change gas-based plants’ structural cost advantage. That most heavily favors fleets in the US and Middle East, as these regions have the highest concentration of ethane-based plants. But that dependence cuts both ways: little flexibility to switch feedstocks if the ethane supply gets disrupted. China: Solidifying its lead in specialty chemicals Specialties were historically a stronghold of the West. But China has established itself as the global leader and is expected to maintain its position (see Figure 2). Figure 2 By 2030, China is expected to capture almost one-third of the global specialty chemicals market Note: Values are rounded Sources: Bain analysis; CEFIC; S&P Global Energy Platts Chinese chemical companies no longer compete on price alone. They now spend more on chemicals R&D than peers in the US or Europe (see Figure 3). Chinese producers have also improved their speed to market and customer service while forming strategic partnerships to accelerate their push into specialties. Figure 3 China’s chemicals R&D spending has increased by more than five times since 2009, outpacing the US and Europe Sources: Bain analysis; CEFIC; S&P Global Energy Platts Carbon fiber demonstrates the shift. Chinese producers are scaling up so quickly that the country’s imports of carbon fiber fell from about 87% of its total supply in 2015 to under 40% last year. China has become the leading producer of mid-range grades of carbon fiber. Its chemicals sector is now targeting the higher-value specialty positions with the same approach. Western policy is responding, but too slowly and in the wrong place. US and EU semiconductor subsidies don’t rebuild specialty-chemical expertise, and “China-plus-one” sourcing can’t replace Chinese supply at scale within the decade. What remains for Western producers is a narrower set of positions protected by regulation, demanding qualification standards, deep customer relationships, or proprietary formulations, and even these are becoming easier to contest as AI accelerates product development. Fragmentation: One global market → five regional blocs The upshot of all of this is a fractured global market with five major blocs. The same product now earns different margins depending on where it’s made and sold. Companies will structure their businesses by region, and the producers that adapt their operational footprint to these forces early will set the next cost curve. Americas: The insulated winner. Cheap ethane gives the region a cost edge of roughly $300 to $400 per tonne, new crackers are still being built, and tariffs are drawing specialty investment back onshore. Europe: The resetting specialty hub. Its carbon rules turn emissions into a genuine cash cost—a penalty of 7% to 10% on polyethylene—so high-cost plants must either absorb that cost or close. A CEFIC report found that about 37 million metric tons of production capacity across all chemicals has closed in Europe since 2022, and reinvestment is limited to high-complexity specialties. China: The scale machine going up-market. It accounts for more than 45% of global chemicals output and about two-thirds of recent ethylene additions. Past self-sufficiency, it’s now exporting its surplus. India: The demand corridor. It’s the fastest-growing petrochemical market at roughly 8% a year, but it’s still import-dependent. That makes it the export market that Chinese producers most want to capture. Middle East: The downstream integrator. It has the lowest-cost commodity position on associated gas. National champions are moving from volume exports into crude-to-chemicals. The regional dynamics bring the industry’s 2030 picture into focus. Base-chemical production will concentrate in the regions with the cheapest feedstock and the most supportive policy; we project close to 70% of ethylene capacity in China, the Middle East, and North America. High-cost plants in Europe and Northeast Asia will continue to close. China will become a net exporter of most base chemicals, so its surplus, not Western demand, will set global trade flows and margins. Returns will be set as much by region and policy as by the cost curve. In commodities, scale and cheap feedstock decide who wins. In specialties, value holds only where it’s genuinely hard to copy—behind regulation, qualification, deep customer integration, or proprietary formulation. As AI spreads, everything else is replicated faster, so the ground worth defending keeps narrowing. What it takes to win The fundamentals haven’t changed, but the dramatically shifting landscape outlines the new shape of a winning chemical company: concentrated in advantaged regions and attractive end markets, holding a clear lead in a small number of chosen products, and running cost, innovation, and AI programs as strategic capabilities. The discipline is to define your winning future position, work backward to what must be true today, and assertively move toward it where a credible path exists. Where it doesn’t, exit or consolidate rather than fund a fight you can’t win. Four principles will guide the era’s most successful companies. If you can’t name your advantage, you don’t have one. Begin with the hardest question: “Where do we actually win—on cost or innovation?” If you can’t answer that clearly, you have a portfolio, not a strategy. Success will require targeting the profit pools in which the company is best positioned, based in part on stress-testing the organization’s advantage across geopolitical, regulatory, and technological scenarios. Reimagine the portfolio, don’t just optimize it. The most effective companies act first on the positions most exposed to competitive threat now, rather than defending everything at once. M&A is the fastest way to act on that choice. Deals should push the company either toward scale and a lower cost position or toward more attractive specialties. Winning companies use M&A to accelerate their journey up the experience curve; good deals buy volume and know-how, not just revenue. Leadership economics are the only ones worth chasing. In some chemical markets, the top few companies capture a disproportionate share of the value, and the fall-off to the rest can be steep. A solid fourth or fifth place isn’t a stable position. In commodities, leadership means having the strongest long-term cost position. In specialties, it’s innovation speed. The most successful companies will use one metric tied to their core economic advantage to guide every decision, such as cost per ton for a commodities producer. In practical terms, that means taking a clean-slate approach to costs and geographic footprint, China exposure included. Closure or conversion decisions on high-cost, carbon-exposed assets should get made within the next 12 to 18 months while the window to reset is open. Get comfortable with an “unreasonable” execution plan. The strategy’s details matter less than how ambitious it is and how hard the company commits to it. Winners set and execute on bold targets for timing, capex, and dividends. A long list of initiatives feels safe, but it spreads money and attention too thin. The most successful companies will prune ruthlessly. AI makes a bold plan doable An unreasonable plan needs a way to move faster. AI is starting to provide one, but most chemical companies haven't capitalized yet. In a 2026 Bain survey, 70% of chemical executives expected AI to have a substantial or transformative effect on their industry, but only 20% said their company had either scaled AI with measurable results or executed a companywide AI transformation. Leaders start to close that gap with deliberate bets on two or three cross-functional domains where AI changes their competitive economics, and they redesign those workflows end to end with agentic AI. For commodity companies, that usually means manufacturing and supply chain. For specialty companies, it's usually R&D and commercial functions. Concentrating on a few domains builds a compounding advantage over time because each redesigned workflow produces data and lessons that speed up the next. The key is redesigning the work and the workforce together and being honest with people about how their roles will change. It's your choice Managed decline is a choice. So is winning. The question is whether you decide your path or let the market decide for you.

Резюме

Despite record plant closures, about 7.5% of olefin capacity must still close by 2030 to return to normal operating rates.
China keeps adding capacity and moving up-market. By 2030, it's expected to hold almost a third of the specialty market.
This year's price spike looks like a recovery, but it's a supply shock. Companies that wait it out will only drift further.
Winners will more definitively choose where they can lead, exit where they can't, and execute an ambitious plan.

The chemical industry’s downturn of the past few years isn’t an ordinary market trough. It’s a structural reset.

Chronic overcapacity has compressed margins. Cheap feedstock has split the industry into haves and have-nots. China is now self-sufficient in most commodity chemicals and is expected to maintain its lead in specialty products—market territory that the West has historically relied on for higher margins. The global market is fracturing into regional blocs, and location and policy set returns as much as the cost curve does. All the while, shocks from the pandemic to this year’s closure of the Strait of Hormuz have battered the industry.

Chemical executives recognize this isn’t a normal downturn, so it’s surprising that most continue to navigate it like they always have: cut costs, protect the balance sheet, and wait for demand to recover. That approach served the industry well for decades, but the transformed playing field makes the old playbook dangerously risky.

Many chemical companies are unwittingly settling into a managed decline. It looks like sound strategy until the moment a rival’s cost or innovation lead becomes insurmountable.

The price rise that followed the Iran conflict has opened a temporary window to reset strategy. Companies that misread the supply shock as a recovery and wait will miss the window.

Overcapacity: Record closures aren’t enough

Overcapacity is the industry’s defining problem of the decade. Bain analysis projects that chemical plants will continue running below their historical utilization average through 2030, and baseline projected demand growth won’t close the gap.

7.5%

estimated net closure of global olefin production capacity required by 2030

We estimate it will likely require the net closure of about 7.5% of global olefin production capacity by 2030, or 35 million metric tons.

It’s a scale of closure the industry has never carried out voluntarily. Europe, Korea, and Japan are cutting capacity, but it’s not enough to offset the pace of China’s capacity additions. In some products, Chinese capacity alone already matches or exceeds total world demand.

Every year that closures fall short of what’s required will delay margin recovery. Furthermore, the gap widens because the lowest-cost producers keep getting cheaper while everyone else stands still.

Feedstock: The divide has widened

Gas-based plants now hold a lasting cost advantage. US ethane is expected to stay roughly $300 to $400 per tonne below the price of Asian naphtha. More than half of the cracker fleets in Europe, East Asia, and Southeast Asia depend on naphtha, making them the most exposed on the map (see Figure 1). China is largely shielded because roughly 40% of its feedstock is coal-based.

Stacked bar chart of regional feedstock mix, with naphtha shown in red. Naphtha supplies 84% of East Asia's feedstock, 61% of Europe's, and 54% of Southeast Asia's, compared with 41% in South Asia, 39% in China, 14% in the Middle East, and 10% in North America. — Europe and parts of Asia are the most exposed to naphtha supply shocks

This year’s widening of the price spread between naphtha and ethane due to the Hormuz disruption is geopolitical noise and doesn’t change gas-based plants’ structural cost advantage. That most heavily favors fleets in the US and Middle East, as these regions have the highest concentration of ethane-based plants. But that dependence cuts both ways: little flexibility to switch feedstocks if the ethane supply gets disrupted.

China: Solidifying its lead in specialty chemicals

Specialties were historically a stronghold of the West. But China has established itself as the global leader and is expected to maintain its position (see Figure 2).

Single stacked bar showing the estimated $911 billion 2030 global specialty chemicals market by region. China has the largest regional share at 31%, followed by North America at 19%, Europe at 15%, and Southeast Asia at 6%, and the rest of the world at 30%. — By 2030, China is expected to capture almost one-third of the global specialty chemicals market

Chinese chemical companies no longer compete on price alone. They now spend more on chemicals R&D than peers in the US or Europe (see Figure 3). Chinese producers have also improved their speed to market and customer service while forming strategic partnerships to accelerate their push into specialties.

Stacked bar chart of chemicals R&D spending in billions of euros for China, the US, and Europe in 2009, 2014, 2019, and 2024. China increased more than five times from €3.2 billion in 2009 to €17.8 billion in 2024, while the US reached €13.1 billion and Europe €10.4 billion. — China’s chemicals R&D spending has increased by more than five times since 2009, outpacing the US and Europe

Carbon fiber demonstrates the shift. Chinese producers are scaling up so quickly that the country’s imports of carbon fiber fell from about 87% of its total supply in 2015 to under 40% last year. China has become the leading producer of mid-range grades of carbon fiber. Its chemicals sector is now targeting the higher-value specialty positions with the same approach.

Western policy is responding, but too slowly and in the wrong place. US and EU semiconductor subsidies don’t rebuild specialty-chemical expertise, and “China-plus-one” sourcing can’t replace Chinese supply at scale within the decade. What remains for Western producers is a narrower set of positions protected by regulation, demanding qualification standards, deep customer relationships, or proprietary formulations, and even these are becoming easier to contest as AI accelerates product development.

Fragmentation: One global market → five regional blocs

The upshot of all of this is a fractured global market with five major blocs. The same product now earns different margins depending on where it’s made and sold. Companies will structure their businesses by region, and the producers that adapt their operational footprint to these forces early will set the next cost curve.

Americas: The insulated winner. Cheap ethane gives the region a cost edge of roughly $300 to $400 per tonne, new crackers are still being built, and tariffs are drawing specialty investment back onshore.
Europe: The resetting specialty hub. Its carbon rules turn emissions into a genuine cash cost—a penalty of 7% to 10% on polyethylene—so high-cost plants must either absorb that cost or close. A CEFIC report found that about 37 million metric tons of production capacity across all chemicals has closed in Europe since 2022, and reinvestment is limited to high-complexity specialties.
China: The scale machine going up-market. It accounts for more than 45% of global chemicals output and about two-thirds of recent ethylene additions. Past self-sufficiency, it’s now exporting its surplus.
India: The demand corridor. It’s the fastest-growing petrochemical market at roughly 8% a year, but it’s still import-dependent. That makes it the export market that Chinese producers most want to capture.
Middle East: The downstream integrator. It has the lowest-cost commodity position on associated gas. National champions are moving from volume exports into crude-to-chemicals.

The regional dynamics bring the industry’s 2030 picture into focus. Base-chemical production will concentrate in the regions with the cheapest feedstock and the most supportive policy; we project close to 70% of ethylene capacity in China, the Middle East, and North America. High-cost plants in Europe and Northeast Asia will continue to close. China will become a net exporter of most base chemicals, so its surplus, not Western demand, will set global trade flows and margins.

Returns will be set as much by region and policy as by the cost curve. In commodities, scale and cheap feedstock decide who wins. In specialties, value holds only where it’s genuinely hard to copy—behind regulation, qualification, deep customer integration, or proprietary formulation. As AI spreads, everything else is replicated faster, so the ground worth defending keeps narrowing.

What it takes to win

The fundamentals haven’t changed, but the dramatically shifting landscape outlines the new shape of a winning chemical company: concentrated in advantaged regions and attractive end markets, holding a clear lead in a small number of chosen products, and running cost, innovation, and AI programs as strategic capabilities.

The discipline is to define your winning future position, work backward to what must be true today, and assertively move toward it where a credible path exists. Where it doesn’t, exit or consolidate rather than fund a fight you can’t win.

Four principles will guide the era’s most successful companies.

If you can’t name your advantage, you don’t have one. Begin with the hardest question: “Where do we actually win—on cost or innovation?” If you can’t answer that clearly, you have a portfolio, not a strategy. Success will require targeting the profit pools in which the company is best positioned, based in part on stress-testing the organization’s advantage across geopolitical, regulatory, and technological scenarios.

Reimagine the portfolio, don’t just optimize it. The most effective companies act first on the positions most exposed to competitive threat now, rather than defending everything at once. M&A is the fastest way to act on that choice. Deals should push the company either toward scale and a lower cost position or toward more attractive specialties. Winning companies use M&A to accelerate their journey up the experience curve; good deals buy volume and know-how, not just revenue.

Leadership economics are the only ones worth chasing. In some chemical markets, the top few companies capture a disproportionate share of the value, and the fall-off to the rest can be steep. A solid fourth or fifth place isn’t a stable position. In commodities, leadership means having the strongest long-term cost position. In specialties, it’s innovation speed. The most successful companies will use one metric tied to their core economic advantage to guide every decision, such as cost per ton for a commodities producer.

In practical terms, that means taking a clean-slate approach to costs and geographic footprint, China exposure included. Closure or conversion decisions on high-cost, carbon-exposed assets should get made within the next 12 to 18 months while the window to reset is open.

Get comfortable with an “unreasonable” execution plan. The strategy’s details matter less than how ambitious it is and how hard the company commits to it. Winners set and execute on bold targets for timing, capex, and dividends. A long list of initiatives feels safe, but it spreads money and attention too thin. The most successful companies will prune ruthlessly.

AI makes a bold plan doable

An unreasonable plan needs a way to move faster. AI is starting to provide one, but most chemical companies haven't capitalized yet. In a 2026 Bain survey, 70% of chemical executives expected AI to have a substantial or transformative effect on their industry, but only 20% said their company had either scaled AI with measurable results or executed a companywide AI transformation.

Leaders start to close that gap with deliberate bets on two or three cross-functional domains where AI changes their competitive economics, and they redesign those workflows end to end with agentic AI. For commodity companies, that usually means manufacturing and supply chain. For specialty companies, it's usually R&D and commercial functions. Concentrating on a few domains builds a compounding advantage over time because each redesigned workflow produces data and lessons that speed up the next.

The key is redesigning the work and the workforce together and being honest with people about how their roles will change.